The global Biosimilars Market, valued at US$32.75 billion in 2024 stood at US$35.04 billion in 2025 and is projected to advance at a resilient ...

The global Biosimilars Market, valued at US$32.75 billion in 2024 stood at US$35.04 billion in 2025 and is projected to advance at a resilient CAGR of 7.5% from 2025 to 2035, culminating in a ...

Sun Pharma shares plunged over 2%, extending losses for the second consecutive session. Notably, it is currently the top ...

The company set the floor price at Rs 340.20 per share, according to an exchange filing on Monday. It may offer a discount of not more than 5% on the floor price.

Here are three stocks to watch from the pharma sector as recommended by market expert Raja Venkatraman for Monday, 16 June ...

Karnataka: Syngene International has announced that the Company has received Establishment Inspection Report (EIR) from US ...

The initial update concerns a Good Clinical Practices (GCP) compliance inspection carried out at Syngene’s Semicon Park ...

India's AI-driven biomanufacturing potential, challenges, and the need for balanced regulations and accountability in a ...

Syngene said that the FDA had reviewed its response and was satisfied with the company’s explanation and its plans for correcting the issues ...

Syngene International said that the United States Food and Drug Administration (US FDA) conducted a good clinical practices (GCP) compliance inspection of the company's facility located at Semicon ...

Bengaluru: In a BSE filing, Syngene International has informed that the company's facility at Semicon Park, Bengaluru has ...